Targeting cancer stem cells enhances multikinase inhibitor therapy in metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma

Journal:

Gut

Published:

2025-12-24

DOI:

10.1136/gutjnl-2025-336527

Affiliations:

6

Authors:

18

Go to article

Institutions	Authors	Share
State Key Laboratory of Digestive Disease, CUHK, China	11.500000 11.500000	0.64
The Chinese University of Hong Kong (CUHK), China	2.500000	0.14
The First Affiliated Hospital, SYSU, China	2.000000	0.11
The University of Hong Kong (HKU), China	1.000000	0.06
The Hong Kong Polytechnic University (PolyU), China	1.000000	0.06

Interested in Oncology and Carcinogenesis?